ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
0.5696
+0.0286 (5.29%)
At close: Oct 8, 2025, 4:00 PM EDT
0.5551
-0.0145 (-2.55%)
After-hours: Oct 8, 2025, 7:58 PM EDT
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $30.65 million as of October 8, 2025. Its market cap has decreased by -16.62% in one year.
Market Cap
30.65M
Enterprise Value
26.21M
1-Year Change
-16.62%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $30.65M, an increase of 40.46%. That is a compound annual growth rate of 2.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 29.11M | -6.04% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | 24.02M | -34.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |